Sphera Funds Management Ltd. Intra Cellular Therapies, Inc. Transaction History
Sphera Funds Management Ltd.
- $545 Million
- Q3 2024
A detailed history of Sphera Funds Management Ltd. transactions in Intra Cellular Therapies, Inc. stock. As of the latest transaction made, Sphera Funds Management Ltd. holds 228,700 shares of ITCI stock, worth $18.9 Million. This represents 0.55% of its overall portfolio holdings.
Number of Shares
228,700Holding current value
$18.9 Million% of portfolio
0.55%Shares
0 transactions
| Quarter | Operation | Price Per share | shares change | shares Held | SEC Form |
|---|
Others Institutions Holding ITCI
# of Institutions
379Shares Held
84.1MCall Options Held
319KPut Options Held
143K-
Vanguard Group Inc Valley Forge, PA9.63MShares$795 Million0.01% of portfolio
-
Black Rock Inc. New York, NY6.32MShares$522 Million0.01% of portfolio
-
Jpmorgan Chase & CO New York, NY5.29MShares$436 Million0.03% of portfolio
-
Wasatch Advisors Inc Salt Lake City, UT3.85MShares$318 Million1.4% of portfolio
-
Avoro Capital Advisors LLC New York, NY3.05MShares$252 Million3.36% of portfolio
About Intra-Cellular Therapies, Inc.
- Ticker ITCI
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 94,401,696
- Market Cap $7.79B
- Description
- Intra-Cellular Therapies, Inc., a biopharmaceutical company, develops novel drugs for the treatment of neuropsychiatric and neurologic diseases by targeting intracellular signaling mechanisms within the central nervous system in the United States. The company offers CAPLYTA for the treatment of schizophrenia in adults. It is also involved in dev...